MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
Chemistry World
January 25, 2013
Rajesh Parishwad
Indian supreme court's anger over unregulated clinical trials The fledgling clinical trials industry in India has been hit by recent revelations of a lack of regulation. Now, the country's supreme court has criticized the body that oversees clinical trials for its inaction in the face of these unethical practices. mark for My Articles similar articles
Chemistry World
October 15, 2013
Dinsa Sachan
Supreme court ruling brings clinical trials to a halt in India The fate of 162 global clinical trials hangs in the balance, as the top Indian court has asked the government to provide more details on their approval process before they can proceed. mark for My Articles similar articles
Chemistry World
August 16, 2013
Dinsa Sachan
Indian U-turn on diabetes drug ban In June the Indian government suspended the popular diabetes drug, pioglitazone, over safety concerns only to revoke the suspension a little over a month later. mark for My Articles similar articles
Pharmaceutical Executive
April 1, 2014
Subramanian et al.
"Market-Based" Price Controls In India? Three strategic implications for pharma pricing strategies in India. mark for My Articles similar articles
Chemistry World
November 12, 2013
Dinsa Sachan
Rough patch for India's clinical trial industry The Indian clinical trial industry is beset by uncertainty. Campaigners have petitioned the courts claiming that drug companies are exploiting poor people and this has led to more than 100 trials being put on hold. mark for My Articles similar articles
Chemistry World
January 7, 2014
Angeli Mehta
Flu drug stockpile may be worthless The case for spending hundreds of millions of pounds stockpiling antivirals for use in a flu pandemic is based on 'judgement rather than on evidence of their effectiveness', according to a parliamentary committee. mark for My Articles similar articles
Chemistry World
August 5, 2014
Dinsa Sachan
Price caps provoke lawsuits from Indian pharma industry The Indian pharma industry is engaged in a pitched battle with the drug price regulator that recently brought certain drugs under price control. mark for My Articles similar articles
Chemistry World
September 6, 2013
Dinsa Sachan
Another drug suspension overturned in India An Indian high court has quashed the suspension of a popular antidepressant. This comes shortly after the suspension of the diabetes drug pioglitazone was overturned. mark for My Articles similar articles
The Motley Fool
June 29, 2010
Brian Orelli
The Final Obstacle to Your Drug Company Multibagger The dreaded FDA advisory committee meeting. mark for My Articles similar articles
Chemistry World
September 18, 2008
James Mitchell Crow
Ranbaxy hit by US drug ban The US Food and Drug Administration (FDA) has banned the import of more than 30 drugs made by Ranbaxy, India's largest drugmaker. mark for My Articles similar articles
Chemistry World
September 17, 2010
Andrew Turley
Free trade could throttle generics from India International agreements on intellectual property threaten the flow of generic HIV drugs from India to developing countries, according to a new report. mark for My Articles similar articles
The Motley Fool
May 14, 2007
Mike Havrilla
A Weaker Amgen Amgen's stock is trading lower after an FDA panel balked at two anemia drugs. mark for My Articles similar articles
Chemistry World
October 8, 2014
Phillip Broadwith
EMA finalizes trial transparency rules The European Medicines Agency has finalized its policy for sharing data from clinical trials. mark for My Articles similar articles
Pharmaceutical Executive
September 1, 2005
Sarah Houlton
Global Report: Kids 'R' EU After years of delay, the European Parliament is ready to vote on pediatric-testing legislation. mark for My Articles similar articles
Chemistry World
April 30, 2014
Emma Stoye
New Zealand in legal highs U-turn Politicians in New Zealand have decided to ban designer drugs from sale in the country, reversing an earlier decision to approve low risk drugs while new laws are put in place. mark for My Articles similar articles
BusinessWeek
April 18, 2005
Manjeet Kripalani
India: Bigger Pharma Tougher patent protection laws are spurring rapid growth in new drug research across India. mark for My Articles similar articles
Chemistry World
March 4, 2013
Andy Extance
UK considers patent rule change for trials The UK has announced plans to amend aspects of its patent law that may be encouraging pharma companies to run their clinical trials in other countries. mark for My Articles similar articles
The Motley Fool
July 8, 2008
Brian Lawler
Blockbuster Drugs Bound for Extinction? One of the biggest classes of prescription drugs, those for diabetes treatments, faces tougher FDA standards. mark for My Articles similar articles
Chemistry World
May 27, 2015
Phillip Broadwith
Label laundry It's been an interesting month in the world of off-label pharmaceuticals. mark for My Articles similar articles
The Motley Fool
March 22, 2010
Brian Orelli
Health-Care Reform Passes! Here's Where to Invest Now Some healthy suggestions for your portfolio. mark for My Articles similar articles
Pharmaceutical Executive
May 1, 2005
Sarah Houlton
Global Report: Iron Fist The United Kingdom is hardening its stance on pharma industry issues. mark for My Articles similar articles
The Motley Fool
December 31, 2007
Brian Lawler
The Anatomy Of An Approved Drug An independent audit by the FDA provides a useful summary of the characteristics of drugs approved by the agency. mark for My Articles similar articles
Chemistry World
July 25, 2012
Pharma Industry May Suffer as India Looks to Generics India plans to provide free generic drugs to half its population. mark for My Articles similar articles
Chemistry World
December 8, 2006
Expert Guidance on Clinical Trial Safety Clinical trial design in the UK is due for a shake up following the recommendations of an expert group commissioned in light of a disastrous trial that left six subjects fighting for their lives. mark for My Articles similar articles
Chemistry World
October 17, 2014
Dinsa Sachan
Indian manufacturers hit back over quality claims The Indian pharmaceutical industry has asked its government to sue authors of a study published by the US National Bureau of Economic Research in early September. mark for My Articles similar articles
Pharmaceutical Executive
July 3, 2007
Thought Leader: Connected Markets, Rob Dhoble It used to be that pharma companies had one marketing strategy for the US and other developed nations, a second strategy for emerging countries, and a third, mostly focused around access, for the developing world. But in a global environment, that doesn't work. mark for My Articles similar articles
The Motley Fool
May 10, 2005
Charly Travers
The Future of Cancer Therapy Biotech firm Exelixis is blazing a trail for long-term success. Should investors take notice? mark for My Articles similar articles
Investment Advisor
September 2008
Asset Allocation, August 2008 Monthly recommendations from the asset allocation panel. mark for My Articles similar articles
The Motley Fool
September 6, 2005
Stephen D. Simpson
FDA's Eye on 2 Potential Blockbusters This week, FDA advisory panels will consider the marketing approval applications of Exubera, the inhaled insulin from Pfizer/Sanofi/Nektar, and Pargluva, the dual PPAR agonist, taken in pill form, from Bristol-Myers and Merck. Investors, take note. mark for My Articles similar articles
Wired
March 2006
Jennifer Kahn
A Nation of Guinea Pigs There's a new outsourcing boom in South Asia - and a billion people are jockeying for the jobs. How India became the global hot spot for drug trials. mark for My Articles similar articles
Registered Rep.
May 29, 2007
Kristen French
Spitzer Forms Panel to Clean up NY Regulation Governor Eliot Spitzer is forming a panel to streamline regulations and make New York more competitive with London, but without sacrificing investor protection. mark for My Articles similar articles
Pharmaceutical Executive
March 1, 2012
Ron Cohen
FDA's Necessary Dose of Reality There's no fast-acting salve, but there are several steps that can be taken to streamline many of the procedures at FDA. And it begins with leadership. mark for My Articles similar articles
The Motley Fool
November 30, 2007
Brian Orelli
Clinical Trial Failures Don't Bother These Companies Contract research organizations, outsourcing companies hired by pharmaceutical and biotech companies to run pre-clinical tests and clinical trials for them, succeed even when drugs fail, and more work may be coming their way. mark for My Articles similar articles
Investment Advisor
July 2008
Asset Allocation, July 2008 Monthly recommendations from IA's asset allocation panel mark for My Articles similar articles
Investment Advisor
June 2008
Asset Allocation, June 2008 Monthly recommendations from this publication's asset allocation panel. mark for My Articles similar articles
Investment Advisor
August 2008
Asset Allocation, August 2008 Monthly recommendations from this publication's asset allocation panel. mark for My Articles similar articles
The Motley Fool
July 12, 2004
Brian Gorman
India Woos U.S. Biotech Companies Business abroad would bode well for investors and consumers. mark for My Articles similar articles
Pharmaceutical Executive
January 1, 2007
Glass & Poli
Forecast 2007: Connecting the Dots How do execs rank the issues facing the pharmaceutical industry? And what are the links they see between them? A new study reveals the industry's mental map of today's challenges. mark for My Articles similar articles
Pharmaceutical Executive
September 1, 2008
Patrick Clinton
Attack of the Junk The United States makes the best medicines in the world. In days to come, that could be a problem. mark for My Articles similar articles
Managed Care
April 2007
MargaretAnn Cross
Do P&T Committees Have Enough Power? Plans and PBMs are divided about sharing drug prices with clinicians. Is it better to have an administrative committee determine the formulary? mark for My Articles similar articles
Chemistry World
May 23, 2012
Andy Extance
Drug watchdogs mark out global territory The US Food and Drug Administration has published plans to ensure that American citizens continue to enjoy access to safe drugs, even as the regulatory pressures of globalization grow. mark for My Articles similar articles
The Motley Fool
September 12, 2005
M.D. Mitchell
Big Problems for Big Pharma Creating new drugs is never easy, but the companies that excel in three key areas are the ones for investors to watch. mark for My Articles similar articles
The Motley Fool
March 28, 2005
Brian Gorman
A Passage to India? Changes in India's patent law could create new dynamics for the biotech and pharmaceutical industries. Investors should be on the lookout for the firms that seek to leverage these new opportunities. mark for My Articles similar articles
Pharmaceutical Executive
January 1, 2012
Jill Wechsler
New Year, New Issues Look for action in 2012 on drug access, shortages, innovation, and transparency. The 800-pound gorilla in the room is the looming Supreme Court decision on the constitutionality of the Obama health reform legislation. mark for My Articles similar articles
BusinessWeek
March 7, 2005
John Carey
Side Effects Of The Drug Scares New fears give rise to a more honest look at the risks for a pill-popping nation. mark for My Articles similar articles
Chemistry World
March 20, 2012
Rajesh Parishwad
India Green Lights Production of Patented Cancer Drug For the first time India has invoked a 'compulsory license' clause to cut the cost of a patented anti-cancer drug by allowing another company to manufacture the therapy. mark for My Articles similar articles
Chemistry World
July 2008
William Bains
Beyond shareholder returns The author offers a new model for the pharmaceutical industry mark for My Articles similar articles
BusinessWeek
August 8, 2005
Manjeet Kripalani
How A Factory Became A Flash Point Violence at a Honda plant highlights India's outdated labor laws and rattles foreign investors. mark for My Articles similar articles
Chemistry World
March 17, 2014
Phillip Broadwith
UK to fast-track access to critical medicines Critically ill patients in the UK could receive new medicines before they are formally approved under a new scheme beginning in April. mark for My Articles similar articles
The Motley Fool
May 21, 2010
Brian Orelli
And You Thought Biotech Was High-Risk, High-Reward Large clinical trials make cardiovascular drugs risky, but the rewards are there, too. mark for My Articles similar articles